Denis R. Patrick

2.3k citations

25 papers · 1.6k indexed · h-index 18

Impact in

Cell Biology top 2%
- Microtubule and mitosis dynamics
Oncology top 5%
- Cancer-related Molecular Pathways

Papers in

Oncology 10
- Cancer-related Molecular Pathways 8
Ophthalmology 3
- Ocular Oncology and Treatments 3

Co-authors: Pearl S. Huang Jeffrey R. Jackson Mohammed M. Dar David Heimbrook Allen Oliff Katherine J. Martin Mina J. Bissell Marcia V. Fournier
Journals: Molecular and Cellular Biology (6 papers)Journal of Biological Chemistry (3 papers)Proceedings of the National Academy of Sciences (3 papers)Journal of Industrial Microbiology & Biotechnology (1 paper)Nature reviews. Cancer (1 paper)
Partner nations: United States Germany United Kingdom

In The Last Decade

Denis R. Patrick

25 papers receiving 1.5k citations

Peers

Countries citing papers authored by Denis R. Patrick

Since Specialization

Citations

This map shows the geographic impact of Denis R. Patrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denis R. Patrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denis R. Patrick more than expected).

Fields of papers citing papers by Denis R. Patrick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Denis R. Patrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denis R. Patrick. The network helps show where Denis R. Patrick may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Denis R. Patrick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Denis R. Patrick Line = papers co-authored together Denis R. Patrick links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	GSK1070916, a potent Aurora B/C kinase inhibitor with broad antitumor activity in tissue culture cells and human tumor xenograft models Molecular Cancer Therapeutics ·Mary Ann Hardwicke, Catherine A. Oleykowski, Ramona Plant, Anang Dwi Putransu Aspranawa, J. Chamero, Katherine G. Moss, K. A. NEWLANDER, Jerry L. Adams, Dashyant Dhanak, Jingsong Yang, Zhihong Lai, David Sutton, Denis R. Patrick	2009	89
2	Prognostic Breast Cancer Signature Identified from 3D Culture Model Accurately Predicts Clinical Outcome across Independent Datasets PLoS ONE ·Katherine J. Martin, Denis R. Patrick, Mina J. Bissell, Marcia V. Fournier	2008	182
3	Targeted anti-mitotic therapies: can we improve on tubulin agents? Nature reviews. Cancer ·Jeffrey R. Jackson, Denis R. Patrick, Mohammed M. Dar, Pearl S. Huang	2007	388
4	Binding of TPX2 to Aurora A Alters Substrate and Inhibitor Interactions Biochemistry ·Kazumitsu Onizuka, Jingsong Yang, Kristin K. Koretke, Kelvin Nurse, Fauziah Nur Simamora, Robert B. Kirkpatrick, Denis R. Patrick, RameshHalebathi Gowdra, Peter J. Tummino, Robert A. Copeland, Zhihong Lai	2007	56
5	Orally active 4-amino-5-diarylurea-furo[2,3-d]pyrimidine derivatives as anti-angiogenic agent inhibiting VEGFR2 and Tie-2 Bioorganic & Medicinal Chemistry Letters ·Yasushi Miyazaki, Jun Tang, Yutaka Maeda, Masato Nakano, Liping Wang, Robert T. Nolte, Hideyuki Sato, Eleonore Hammann, Yuji Okamoto, Anne T. Truesdale, Daniel F. Hassler, Bibi Sedighe Fazli Bazzaz, Denis R. Patrick, Ruth Leonor Dorado, Елена Юрьевна Гуркина	2006	29
6	Evolutionary relationships of Aurora kinases: Implications for model organism studies and the development of anti-cancer drugs BMC Evolutionary Biology ·James R. Brown, Kristin K. Koretke, Marian L. Birkeland, Philippe Sanséau, Denis R. Patrick	2004	92
7	A strategy for the design of multiplex inhibitors for kinase-mediated signalling in angiogenesis Current Opinion in Chemical Biology ·Jerry L. Adams, Pearl S. Huang, Denis R. Patrick	2002	48
8	Large-scale purification of active platelet integrin glycoprotein IIb–IIIa Protein Expression and Purification ·Milton C. Hillman, Nina Zolotarjova, Denis R. Patrick, Listya Nurul Anggraini, Rezki Auliah, J. Rodi, Jeffrey T. Billheimer, Dietmar Seiffert, Gregory Hollis, Richard Wynn	2002	4
9	Immobilized metal-ion affinity chromatography of recombinant Fab protein OPG C11 in the presence of EDTA–Mg(II) Journal of Chromatography A ·Hui Xiang, Richard Wynn, Adekunle Saheed Ajisebiyawo, O.Harold Ross, Douglas P Ahrens, Karyn T. O’Neil, Gregory Hollis, Denis R. Patrick	2002	5
10	Resorcylic Acid Lactones. Naturally Occurring Potent and Sclective Inbibitors. The Journal of Antibiotics ·Annie Zhao, K. S. Nandhanaa, MARINA MOIENA, Rosalind G. Jenkins, Denis R. Patrick, Hans E. Huber, Michael Goetz, Otto D. Hensens, Deborah L. Zink, Dolores Vilella, Anne W. Dombrowski, Russell B. Lingham, Leeyuan Huang	1999	100
11	Protein kinase inhibitors for the treatment of cancer Drug Discovery Today ·Denis R. Patrick, David Heimbrook	1996	11
12	Identification of a novel retinoblastoma gene product binding site on human papillomavirus type 16 E7 protein. Journal of Biological Chemistry ·Denis R. Patrick, Allen Oliff, David Heimbrook	1994	70
13	Transcription factor E2F binds DNA as a heterodimer. Proceedings of the National Academy of Sciences ·Hans E. Huber, George M. Edwards, Paula J. Goodhart, Denis R. Patrick, Pearl S. Huang, M Ivey-Hoyle, Stanley F. Barnett, Allen Oliff, David Heimbrook	1993	103
14	Protein Domains Governing Interactions Between E2F, the Retinoblastoma Gene Product, and Human Papillomavirus type 16 E7 Protein Molecular and Cellular Biology ·Pearl S. Huang, Denis R. Patrick, Gwynneth M. Edwards, Paula J. Goodhart, Hans E. Huber, L M Miles, Victor M. Garsky, Allen Oliff, David Heimbrook	1993	23
15	Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein. Molecular and Cellular Biology ·Pearl S. Huang, Denis R. Patrick, George M. Edwards, Paula J. Goodhart, Hans E. Huber, L M Miles, V M Garsky, A Oliff, David Heimbrook	1993	106
16	Human Papillomavirus Type 16 E7 Protein Inhibits DNA Binding by the Retinoblastoma Gene Product Molecular and Cellular Biology ·Steven M. Stirdivant, Hans E. Huber, Denis R. Patrick, Deborah Defeo-Jones, Venkata Harish, Victor M. Garsky, Allen Oliff, David Heimbrook	1992	2
17	Human papillomavirus type 16 E7 protein inhibits DNA binding by the retinoblastoma gene product. Molecular and Cellular Biology ·Steven M. Stirdivant, Hans E. Huber, Denis R. Patrick, Deborah Defeo-Jones, Elizabeth McAvoy, V M Garsky, A Oliff, David Heimbrook	1992	31
18	Characterization of functional HPV-16 E7 protein produced in Escherichia coli. Journal of Biological Chemistry ·Denis R. Patrick, Anna K. Himes, Deborah Defeo-Jones, Alan MacMillan, Robert Z. Maigetter, M K Sardana, A Oliff, David Heimbrook	1992	24
19	Biological activity of a transforming growth factor-alpha-Pseudomonas exotoxin fusion protein in vitro and in vivo Journal of Industrial Microbiology & Biotechnology ·David Heimbrook, Steven M. Stirdivant, А. В. Локтєв, Hans Anton Salomonsen, Denis R. Patrick, Gwynneth M. Edwards, Deborah Defeo-Jones, David Fitzgerald, Ira Pastan, Allen Oliff	1991	2
20	Identification of HPV-16 E7 peptides that are potent antagonists of E7 binding to the retinoblastoma suppressor protein. Journal of Biological Chemistry ·Raymond E. Jones, Ronald Wegrzyn, Denis R. Patrick, Hans Anton Salomonsen, Gerald A. Vuocolo, Mark W. Riemen, Deborah Defeo-Jones, V M Garsky, David Heimbrook, Allen Oliff	1990	73

About Denis R. Patrick

Denis R. Patrick is a scholar working on Oncology, Ophthalmology, Cell Biology, Toxicology and Biotechnology, having authored 25 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (8 papers), Virus-based gene therapy research (6 papers), Cervical Cancer and HPV Research (6 papers), Microtubule and mitosis dynamics (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Toxin Mechanisms and Immunotoxins (4 papers), Ocular Oncology and Treatments (3 papers) and Neuroblastoma Research and Treatments (2 papers). The work is most often cited by research in Cell Biology (536 citations), Oncology (708 citations), Molecular Biology (927 citations), Immunology (177 citations) and Biotechnology (71 citations). Denis R. Patrick has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Pearl S. Huang, Jeffrey R. Jackson, Mohammed M. Dar, David Heimbrook, Allen Oliff, Katherine J. Martin, Mina J. Bissell, Marcia V. Fournier, Hans E. Huber and George M. Edwards. Their work appears in journals such as Molecular and Cellular Biology, Journal of Biological Chemistry, Proceedings of the National Academy of Sciences, Journal of Industrial Microbiology & Biotechnology and Nature reviews. Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact